Early Cardiovascular Risk Assessment of Patients With COPD During Respiratory Exacerbation for the Identification and Treatment of Cardiovascular Comorbidity

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Documented COPD (based on lung function tests, symptoms and relevant treatment).

• Aged 18-75 years.

• Mentally competent to understand and follow medical recommendations.

Locations
Other Locations
Israel
Tel-Aviv Sourasky Medical Center
RECRUITING
Tel Aviv
Contact Information
Primary
Ophir Freund, MD
Ophirf@tlvmc.gov.il
+972-545-305648
Time Frame
Start Date: 2025-03-01
Estimated Completion Date: 2027-08-01
Participants
Target number of participants: 150
Treatments
Experimental: Intervention
Patients will be evaluated by a pulmonologist during their admission, in addition to a cardiologist, aiming to identify cardiovascular comorbidities including dyslipidemia, diabetes, hypertension, ischemic heart disease, heart failure, valvular disease, personal or family history of ischemic heart disease, and smoking. Part of the evaluation will include assessing the management of diagnosed cardiovascular conditions. Finally, recommendations for further investigation or initiation of drug treatment will be made.
Active_comparator: Control
Patients will be evaluated by a pulmonologist during their hospitalization, who will focus on their pulmonary condition, optimize basic treatment, and recommend continued follow-up as needed.
Sponsors
Leads: Tel-Aviv Sourasky Medical Center
Collaborators: AstraZeneca

This content was sourced from clinicaltrials.gov